Sander van Tilburg

Sander van Tilburg is a researcher at Erasmus MC specializing in Pharmacy and translational research on autoimmune and neurological disorders.

• Primary focus on Guillain-Barré syndrome (GBS) and systemic lupus erythematosus (SLE)
• Expertise in biomarker discovery (e.g., neurofilament light chain)
• Investigating pharmacodynamics of intravenous immunoglobulin therapies

His work integrates immunology, neurology, and pharmacogenomics to improve diagnostic and therapeutic approaches for neuroimmunological diseases.

Research trends from his publications highlight:

• Quantification of neurofilament light chain as a prognostic biomarker in GBS
• Genetic variation in Fc-gamma receptors influencing immunoglobulin therapy efficacy
• Development of novel immunomodulatory strategies for autoimmune diseases

Recent collaborations span international institutions, focusing on neuroimmunology and therapeutic drug monitoring.